UCLA Health receives $1.72 million grant to advance brain tumor research and training

Investigators at the UCLA Health Jonsson Comprehensive Cancer Center have been awarded a $1.72 million grant from the National Institutes of Health to support the Neuro-Oncology Translational Research Training Program, an initiative designed to train the next generation of brain tumor scientists and physician-scientists.

Nonsteroidal Topical OK’d for Atopic Dermatitis

The FDA approved tapinarof cream 1% (Vtama) for eczema in individuals ages 2 years and older, drugmaker Organon announced on Monday. Approval of the topical

December 18, 2024

Daylight saving time ends next weekend. This is how to prepare for the potential health effects. – The Cannabist

The good news: You will get a glorious extra hour of sleep. The bad: It’ll be dark as a pocket by late afternoon for the

October 27, 2024

ARCH, F-Prime and Mubadala pump $200M into former Denali programs

A new startup has emerged with $200 million and access to multiple preclinical drug candidates from neuroscience drugmaker Denali Therapeutics. On Wednesday morning, South San

January 9, 2025

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.